Change of Adviser
December 03 2010 - 1:00AM
UK Regulatory
TIDMGWP
RNS Number : 2951X
GW Pharmaceuticals PLC
03 December 2010
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company")
CHANGE OF ADVISER
and
Notification re Schedule 2 paragraph (g) of the AIM Rules
Porton Down, UK, 3 December 2010: GW Pharmaceuticals (AIM: GWP) today announces
that it has appointed Peel Hunt Limited as Nominated Adviser and broker to the
Company with immediate effect.
The Company also provides notification in accordance with the AIM Rules that Mr
James Noble, a non-executive director of the Company, was previously a Director
of Axellis Limited ("Axellis") which entered into a creditors' voluntary
liquidation on 26 July 2010.
For further information, please contact:
+------------------------------------+------------------------+
| GW Pharmaceuticals PLC | +44 (0)1980 557 000 |
+------------------------------------+------------------------+
| Adam George, Company Secretary | |
+------------------------------------+------------------------+
| | |
+------------------------------------+------------------------+
| Peel Hunt Limited (Nominated | +44 (0) 20 7418 8900 |
| Adviser) | |
+------------------------------------+------------------------+
| James Steel | |
| Vijay Barathan | |
+------------------------------------+------------------------+
| | |
+------------------------------------+------------------------+
| Financial Dynamics | + 44 (0) 20 7831 3113 |
+------------------------------------+------------------------+
| Ben Atwell / John Dineen | |
+------------------------------------+------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
APPQLLFBBLFBFBB
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Gw Pharmaceuticals (LSE:GWP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about GW Pharm. (London Stock Exchange): 0 recent articles
More Gw Pharmaceuticals News Articles